J
John Skidmore
Researcher at University of Cambridge
Publications - 37
Citations - 2125
John Skidmore is an academic researcher from University of Cambridge. The author has contributed to research in topics: Biology & Oxadiazole. The author has an hindex of 12, co-authored 31 publications receiving 1549 citations. Previous affiliations of John Skidmore include GlaxoSmithKline.
Papers
More filters
Journal ArticleDOI
Autophagy and Neurodegeneration: Pathogenic Mechanisms and Therapeutic Opportunities
Fiona M. Menzies,Angeleen Fleming,Andrea Caricasole,Carla F. Bento,Stephen P. Andrews,Avraham Ashkenazi,Jens Füllgrabe,Anne Jackson,Maria Jimenez Sanchez,Cansu Karabiyik,Floriana Licitra,Ana Lopez Ramirez,Mariana Pavel,Claudia Puri,Maurizio Renna,Thomas Ricketts,Lars Schlotawa,Mariella Vicinanza,Hyeran Won,Ye Zhu,John Skidmore,David C. Rubinsztein +21 more
TL;DR: How autophagy upregulation may be a therapeutic strategy in a wide range of neurodegenerative conditions is described and possible pathways and druggable targets that may be suitable for this objective are considered.
Journal ArticleDOI
Small molecules, big targets: drug discovery faces the protein–protein interaction challenge
TL;DR: The research leading to breakthroughs in PPI inhibition is described and the existence of groups of structurally related PPIs within the PPI target class is highlighted to illustrate the research strategies that have proved most useful.
Journal ArticleDOI
The different autophagy degradation pathways and neurodegeneration
Angeleen Fleming,Mathieu Bourdenx,M Fujimaki,Cansu Karabiyik,Gregory J. Krause,Ana Lopez,Adrián Martín-Segura,Claudia Puri,Aurora Scrivo,John Skidmore,Sung Min Son,Eleanna Stamatakou,Lidia Wrobel,Ye Zhu,Ana Maria Cuervo,David C. Rubinsztein +15 more
TL;DR: The term autophagy encompasses different pathways that route cytoplasmic material to lysosomes for degradation and includes macroautophagy, chaperone-mediated autophathy, and microautophathy as discussed by the authors .
Journal ArticleDOI
Total synthesis of (−)-nakadomarin A
TL;DR: A highly diastereoselective bifunctional organocatalyst controlled Michael addition, a nitro-Mannich/lactamization cascade, a furan N-acyliminium cyclisation, a sequential alkyne RCM/syn-reduction and an alkene RCM has allowed a 19 step, highly stereoselectives synthesis of (-)-nakadomarin A.
Journal ArticleDOI
New procedures for the Juliá–Colonna asymmetric epoxidation: synthesis of (+)-clausenamide
Michael W. Cappi,Robert W. Flood,Stanley M. Roberts,John Skidmore,Natalie M. Williamson,Weiping Chen,Yong-Wei Liao,John A. Smith +7 more
TL;DR: In this article, a 15-mer or 20-mer poly-L-leucine bound to a PEG-based support was used as an immobilised catalysts in a fixed-bed reactor.